An open-label phase II trial of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity by Isabel H. Gonzalez-Bocco, Rayven Frierson, Alyssa Cho, Fabiola A. Reyes Curcio, Andres E. Franceschi, Chloe Lahoud, Dimitrios G. Moshovitis, Katherine Beluch, Manu Balusu, C. Elizabeth Keleher, Keri M. Sullivan, Michael Dougan, Qianwen Wang, Jennifer H. Han, Ahmed Nader, Alicia Aylott, Wei Wang, Brian T. Chan, Sarah P. Hammond, Jennifer Manne-Goehler, Sophia Koo

Get full text